Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) EV-to-EBITDA : 0.00 (As of May. 15, 2024)

Chardan Healthcare Acquisition 2 EV-to-EBITDA Chart

Competitive Comparison of Chardan Healthcare Acquisition 2's EV-to-EBITDA

For the Shell Companies subindustry, Chardan Healthcare Acquisition 2's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chardan Healthcare Acquisition 2's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Chardan Healthcare Acquisition 2's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Chardan Healthcare Acquisition 2's EV-to-EBITDA falls into.

Chardan Healthcare Acquisition 2 EV-to-EBITDA Calculation

Chardan Healthcare Acquisition 2's EV-to-EBITDA for today is calculated as:

Chardan Healthcare Acquisition 2's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chardan Healthcare Acquisition 2's EBITDA for the trailing twelve months (TTM) ended in Jun. 2021 was $-2.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chardan Healthcare Acquisition 2  (AMEX:CHAQ.WS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Chardan Healthcare Acquisition 2's PE Ratio for today is calculated as:

Chardan Healthcare Acquisition 2's share price for today is $0.72.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chardan Healthcare Acquisition 2's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Chardan Healthcare Acquisition 2 EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Chardan Healthcare Acquisition 2's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) Business Description